Yesterday, Oddity Tech, the parent company behind Il Makiage and SpoiledChild, has once again raised its full-year financial forecast following a strong second-quarter performance, while unveiling plans to expand into the medical-grade skincare market with the launch of a new telehealth brand.
For the fiscal year ending December 31, Oddity now expects net revenue between $799 million and $804 million, up from its previous forecast of $790 million to $798 million. Adjusted diluted earnings per share are projected to reach $2.06 to $2.09, compared to the earlier range of $1.99 to $2.04.
In Q2 2025, Oddity reported net revenue of $241 million, a notable increase from $193 million in the same period last year, beating analyst expectations of $238 million. Net income rose to $49 million, up from $45 million in Q2 2024, while adjusted diluted EPS climbed to 92 cents, surpassing Wall Street’s forecast of 84 cents.
“These strong financials allow us to continue reinvesting in our future, including technology, Oddity Labs and building new brands,” said Oran Holtzman, cofounder and CEO of Oddity.
The company is preparing to launch its third brand in the fourth quarter of 2025—a telehealth platform focused on medical-grade skin and body care solutions. The new brand will mark Oddity’s strategic entry into the healthcare space, specifically dermatology, leveraging its proprietary tech and direct-to-consumer model to disrupt a new category. A fourth brand is also in development and is expected to launch in 2026.
“The upcoming launch of brand three opens up a massive new market for us,” Holtzman said. “Just as we used technology and our direct-to-consumer model to transform beauty, we are turning our sights toward health care, starting with dermatology, where we see a strong and profitable runway.”
